Literature DB >> 19235496

Evidence for the use of intramuscular injections in outpatient practice.

Mark Shatsky1.   

Abstract

There are few studies comparing the outcomes of patients who are treated with oral versus intramuscular antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, or vitamin B12. This may lead to confusion about when the intramuscular route is indicated. For example, intramuscular ceftriaxone for Neisseria gonorrhoeae infection and intramuscular penicillin G benzathine for Treponema pallidum infection are the treatments of choice. However, oral antibiotics are the treatment of choice for the outpatient treatment of pneumonia and most other outpatient bacterial infections. Oral corticosteroids are as effective as intramuscular corticosteroids and are well-tolerated by most patients. High daily doses of oral vitamin B12 with ongoing clinical surveillance appear to be as effective as intramuscular treatment. Few data support choosing intramuscular ketorolac over an oral nonsteroidal anti-inflammatory drug unless the patient is unable to tolerate an oral medication. For other indications, the intramuscular route should be considered only when the delivery of a medication must be confirmed, such as when a patient cannot tolerate an oral medication, or when compliance is uncertain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235496

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

Review 1.  Improving Injectable Medicines Prescription in Outpatient Services: A Path Towards Rational Use of Medicines in Iran.

Authors:  Firoozeh Bairami; Fatemeh Soleymani; Arash Rashidian
Journal:  Int J Health Policy Manag       Date:  2016-03-05

Review 2.  Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?

Authors:  Robert L Barkin; Mihail Beckerman; Steven L Blum; Frank M Clark; Eun-Kyu Koh; Dickson S Wu
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 3.923

3.  Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12).

Authors:  Teresa Sanz-Cuesta; Paloma González-Escobar; Rosario Riesgo-Fuertes; Sofía Garrido-Elustondo; Isabel del Cura-González; Jesús Martín-Fernández; Esperanza Escortell-Mayor; Francisco Rodríguez-Salvanés; Marta García-Solano; Rocío González-González; María Ángeles Martín-de la Sierra-San Agustín; Carmen Olmedo-Lucerón; María Luisa Sevillano Palmero; Carmen Mateo-Ruiz; Beatriz Medina-Bustillo; Antonio Valdivia-Pérez; Francisca García-de Blas-González; José Enrique Mariño-Suárez; Ricardo Rodríguez-Barrientos; Gloria Ariza-Cardiel; Luisa María Cabello-Ballesteros; Elena Polentinos-Castro; Milagros Rico-Blázquez; Ma Teresa Rodríguez-Monje; Sonia Soto-Díaz; Susana Martín-Iglesias; Ramón Rodríguez-González; Irene Bretón-Lesmes; María Vicente-Herrero; Jesús Sánchez-Díaz; Tomás Gómez-Gascón; Mercedes Drake-Canela; Ángel Asúnsolo-del Barco
Journal:  BMC Public Health       Date:  2012-05-31       Impact factor: 3.295

4.  Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics.

Authors:  Naidong Ye; Scott A Monk; Pankaj Daga; David M Bender; Laura B Rosen; Jamie Mullen; Margaret C Minkwitz; Alan R Kugler
Journal:  Clin Pharmacol Drug Dev       Date:  2018-01-10

5.  Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12).

Authors:  Teresa Sanz-Cuesta; Esperanza Escortell-Mayor; Isabel Cura-Gonzalez; Jesus Martin-Fernandez; Rosario Riesgo-Fuertes; Sofía Garrido-Elustondo; Jose Enrique Mariño-Suárez; Mar Álvarez-Villalba; Tomás Gómez-Gascón; Inmaculada González-García; Paloma González-Escobar; Concepción Vargas-Machuca Cabañero; Mar Noguerol-Álvarez; Francisca García de Blas-González; Raquel Baños-Morras; Concepción Díaz-Laso; Nuria Caballero-Ramírez; Alicia Herrero de-Dios; Rosa Fernández-García; Jesús Herrero-Hernández; Belen Pose-García; María Luisa Sevillano-Palmero; Carmen Mateo-Ruiz; Beatriz Medina-Bustillo; Monica Aguilar-Jiménez
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.